Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9038)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu DW, Wan P, Xia Q. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World J Gastroenterol 2016; 22(12): 3325-3334 [PMID: 27022214 DOI: 10.3748/wjg.v22.i12.3325] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i12/3325.htm |
| Number | Citing Articles |
| 1 |
Peter R. Galle, Francesco Tovoli, Friedrich Foerster, Marcus A. Wörns, Alessandro Cucchetti, Luigi Bolondi. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. Journal of Hepatology 2017; 67(1): 173 doi: 10.1016/j.jhep.2017.03.007
|
| 2 |
F.J. León Díaz, J.A. Pérez Daga, B. Sánchez Pérez, J.L. Fernández Aguilar, C. Montiel Casado, J.M. Aranda Narváez, M.A. Suárez Muñoz, L. Romacho López, J. Santoyo Villalba, J. Santoyo Santoyo. Up-to-7 Criteria for Hepatocellular Carcinoma Liver Transplantation: A Retrospective Analysis of Experiences. Transplantation Proceedings 2016; 48(9): 2969 doi: 10.1016/j.transproceed.2016.08.035
|
| 3 |
Wei Yang, Hao Wu, Zhong-yi Zhang, Jung-chieh Lee, Song Wang, Yan-jie Wang, Wei Wu, Min-hua Chen, Kun Yan. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation. International Journal of Hyperthermia 2018; 34(1): 68 doi: 10.1080/02656736.2017.1324179
|
| 4 |
Byeong Geun Song, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Jae-Won Joh, Gyu-Seong Choi. Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2020; 52(3): 881 doi: 10.1016/j.transproceed.2020.01.037
|
| 5 |
Gian Piero Guerrini, Giuseppe Esposito, Tiziana Olivieri, Paolo Magistri, Roberto Ballarin, Stefano Di Sandro, Fabrizio Di Benedetto. Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis. Cancers 2022; 14(14): 3465 doi: 10.3390/cancers14143465
|
| 6 |
Pedro Eman, Eduardo Chacon, Meera Gupta, Jonathan C. Berger, Malay B. Shah, Hanine E. El Haddad, Amr El-Husseini, Anna C. Dela Cruz, Alla Grigorian, Xiaonan Mei, Roberto Gedaly. Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infection. HPB 2019; 21(8): 1009 doi: 10.1016/j.hpb.2019.01.001
|
| 7 |
Bing Han, Han Ding, Shuai Zhao, Yichi Zhang, Jian Wang, Yue Zhang, Jinyang Gu. Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.562103
|
| 8 |
David C. Mulligan. The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond. Hepatology 2016; 64(6): 1853 doi: 10.1002/hep.28841
|
| 9 |
Hae Won Lee, Kyung-Suk Suh. Advancements of liver transplantation for hepatocellular carcinoma in Korea. Japanese Journal of Clinical Oncology 2017; 47(2): 93 doi: 10.1093/jjco/hyw168
|
| 10 |
Sami Akbulut, Cemalettin Koc. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?. Journal of Gastrointestinal Cancer 2020; 51(4): 1107 doi: 10.1007/s12029-020-00482-0
|
| 11 |
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
|
| 12 |
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective. Digestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
|
| 13 |
Sam E. Grigg, Gino L. Sarri, Paul J. Gow, Neville D. Yeomans. Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2019; 49(10): 1260 doi: 10.1111/apt.15253
|
| 14 |
Douglas N. VanDerwerken, Nicholas L. Wood, Dorry L. Segev, Sommer E. Gentry. The Precise Relationship Between Model for End‐Stage Liver Disease and Survival Without a Liver Transplant. Hepatology 2021; 74(2): 950 doi: 10.1002/hep.31781
|
| 15 |
Can KARACA, Cahit Hüseyin YILMAZ. Hepatoselüler kanser için karaciğer nakli: Altı yıllık deneyimin öğrettikleri. Ege Tıp Dergisi 2020; 59(4): 265 doi: 10.19161/etd.834132
|
| 16 |
Mei-Yun Wu, Cheng-Hsi Yeh, Chien-Chang Liao, Chao-Long Chen, Chih-Chi Wang, Chih-Che Lin, Wan- Ching Chang, Yu-Fan Cheng, Hsin-You Ou. Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2024; doi: 10.1016/j.transproceed.2023.12.008
|
| 17 |
C. Yilmaz, C.A. Karaca, Z. Iakobadze, R. Farajov, K. Kilic, L. Doganay, M. Kilic. Factors Affecting Recurrence and Survival After Liver Transplantation for Hepatocellular Carcinoma. Transplantation Proceedings 2018; 50(10): 3571 doi: 10.1016/j.transproceed.2018.05.027
|
| 18 |
Jie Han, Yu-chen Fan, Kai Wang. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma. Medicine 2020; 99(43): e22703 doi: 10.1097/MD.0000000000022703
|
| 19 |
Julia Herreras, Tommaso Di Maira, Carmen Vinaixa, Fernando San Juan, Ángel Rubín, Marina Berenguer. Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation. Transplantation Direct 2019; 5(10): e487 doi: 10.1097/TXD.0000000000000934
|
| 20 |
Baoxian Liu, Guangliang Huang, Xiaohua Xie, Qiang Zhao, Liya Su, Ming Liu, Xiaoju Li, Jianting Long, Ming Kuang, Xiaoyan Xie. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience. International Journal of Hyperthermia 2020; 37(1): 1202 doi: 10.1080/02656736.2020.1834154
|
| 21 |
Madalyn G. Neuwirth, Christine Bierema, Andrew J. Sinnamon, Douglas L. Fraker, Rachel R. Kelz, Robert E. Roses, Giorgos C. Karakousis. Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?. Cancer 2018; 124(1): 125 doi: 10.1002/cncr.30977
|
| 22 |
John Fung, Diego DiSabato, Chih-Yi Liao, Osmanuddin Ahmed, Anjana Pillai. Perspective: Advances in liver transplantation for hepatocellular carcinoma – A prototype for transplant oncology. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 4 doi: 10.1016/j.hbpd.2022.09.003
|
| 23 |
Naimish N. Mehta, Srinivas Bojanapu. Peri-operative Anesthetic Management in Liver Transplantation. 2023; : 95 doi: 10.1007/978-981-19-6045-1_7
|
| 24 |
Y. Shi, J. Chi, T. Wang, D. Cui, X. Tang, M. Ding, P. Li, B. Zhai. Mid-term outcome of percutaneous thermal ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation. Clinical Radiology 2019; 74(9): 735.e1 doi: 10.1016/j.crad.2019.05.029
|
| 25 |
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Paolo Giunchedi. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials 2020; 10(5): 870 doi: 10.3390/nano10050870
|
| 26 |
Patrizia Burra, Alberto Zanetto, Giacomo Germani. Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma. Cancers 2018; 10(2): 46 doi: 10.3390/cancers10020046
|
| 27 |
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
|
| 28 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
|
| 29 |
Berend R. Beumer, Jeroen L.A. van Vugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Malgorzata Nowosad, William Bennet, Emmanouil Tsochatzis, Evangelia Koutli, Fariba Abbassi, Marco P.A.W. Claasen, Manuela Merli, Joanne O'Rourke, Martina Gambato, Alberto Benito, Avik Majumdar, Ek Khoon Tan, Maryam Ebadi, Aldo J. Montano‐Loza, Marina Berenguer, Herold J. Metselaar, Wojciech G. Polak, Vincenzo Mazzaferro, Jan N.M. IJzermans. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria. Journal of Cachexia, Sarcopenia and Muscle 2022; 13(5): 2373 doi: 10.1002/jcsm.13053
|
| 30 |
Sam Grigg, Paul Gow, Neville Yeomans. Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma. Journal of Investigative Surgery 2020; 33(4): 389 doi: 10.1080/08941939.2018.1513103
|